AXLA

After SVB Securities and Noble Financial gave Axcella Health (NASDAQ: AXLA) a Buy rating last month, the company received another Buy, this time from H.C. Wainwright. Analyst Ed Arce maintained a Buy rating on Axcella Health today and set a price target of $8.00. The company's shares closed last Tuesday at $2.03. According to TipRanks.com, Arce is a 4-star analyst with an average return of 6.6% and a 37.6% success rate. Arce covers the Healthcare sector, focusing on stocks such as Aurinia Pharmaceuticals, Paratek Pharmaceuticals, and Galmed Pharmaceuticals. Currently, the analyst consensus on Axcella Health is a Strong Buy with an average price target of $8.00, implying a 294.
https://www.tipranks.com/news/blurbs/axcella-health-axla-received-its-third-buy-in-a-row-5?utm_source=advfn.com&utm_medium=referral